|4Jun 10, 4:03 PM ET

Davis Jason 4

4 · FibroBiologics, Inc. · Filed Jun 10, 2025

Insider Transaction Report

Form 4
Period: 2025-06-09
Davis Jason
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-06-09+450,000450,000 total
    Exercise: $0.94Exp: 2035-06-08Common Stock (450,000 underlying)
Footnotes (1)
  • [F1]On June 9, 2025, the reporting person was granted an option to purchase 450,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Documents

1 file
  • 4
    ownership.xmlPrimary